258 related articles for article (PubMed ID: 22564838)
1. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.
Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Denis O; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2012 Jul; 56(7):3700-11. PubMed ID: 22564838
[TBL] [Abstract][Full Text] [Related]
2. Influence of the protein kinase C activator phorbol myristate acetate on the intracellular activity of antibiotics against hemin- and menadione-auxotrophic small-colony variant mutants of Staphylococcus aureus and their wild-type parental strain in human THP-1 cells.
Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2012 Dec; 56(12):6166-74. PubMed ID: 22985883
[TBL] [Abstract][Full Text] [Related]
3. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.
Nguyen HA; Denis O; Vergison A; Theunis A; Tulkens PM; Struelens MJ; Van Bambeke F
Antimicrob Agents Chemother; 2009 Apr; 53(4):1434-42. PubMed ID: 19188393
[TBL] [Abstract][Full Text] [Related]
4. Intracellular forms of menadione-dependent small-colony variants of methicillin-resistant Staphylococcus aureus are hypersusceptible to β-lactams in a THP-1 cell model due to cooperation between vacuolar acidic pH and oxidant species.
Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2012 Dec; 67(12):2873-81. PubMed ID: 23002174
[TBL] [Abstract][Full Text] [Related]
5. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
[TBL] [Abstract][Full Text] [Related]
6. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Mélard A; Garcia LG; Das D; Rozenberg R; Tulkens PM; Van Bambeke F; Lemaire S
J Antimicrob Chemother; 2013 Mar; 68(3):648-58. PubMed ID: 23188792
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
[TBL] [Abstract][Full Text] [Related]
8. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
Begic D; von Eiff C; Tsuji BT
J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.
Belley A; Arhin FF; Sarmiento I; Deng H; Rose W; Moeck G
Antimicrob Agents Chemother; 2013 Jan; 57(1):205-11. PubMed ID: 23089749
[TBL] [Abstract][Full Text] [Related]
12. Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.
Peyrusson F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358297
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Steed ME; Vidaillac C; Rybak MJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):955-9. PubMed ID: 22123693
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Seral C; Van Bambeke F; Tulkens PM
Antimicrob Agents Chemother; 2003 Jul; 47(7):2283-92. PubMed ID: 12821480
[TBL] [Abstract][Full Text] [Related]
15. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Akins RL; Rybak MJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1925-9. PubMed ID: 10858356
[TBL] [Abstract][Full Text] [Related]
17. Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Vidaillac C; Rybak MJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2928-33. PubMed ID: 19414568
[TBL] [Abstract][Full Text] [Related]
18. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype.
von Eiff C; McNamara P; Becker K; Bates D; Lei XH; Ziman M; Bochner BR; Peters G; Proctor RA
J Bacteriol; 2006 Jan; 188(2):687-93. PubMed ID: 16385058
[TBL] [Abstract][Full Text] [Related]
19. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
20. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
